Scientists have created a pre-clinical weight loss drug combining GLP-1, GIP, glucagon and peptide YY hormones to match bariatric surgery effectiveness.
‘Next Ozempic’ aims to deliver 30% weight loss with fewer side effects
Scientists have created a pre-clinical weight loss drug combining GLP-1, GIP, glucagon and peptide YY hormones to match bariatric surgery effectiveness.